Drug Topics

DECEMBER 22, 2022

CBD is a hot topic on the internet and social media, but large percentages of posts are making therapeutic claims that are not FDA approved or backed by enough research.

FDA 174

FDA 174

Drug Topics

SEPTEMBER 7, 2022

CBD products range from gummies to tinctures to topical lotions and creams.

212

212

Drug Topics

SEPTEMBER 10, 2022

Tips to help your pharmacy stand out as a knowledgeable CBD retailer.

Independent Pharmacies 212

Independent Pharmacies 212

Drug Topics

NOVEMBER 9, 2022

Learn more about the difference between CBD and THC—and why it matters.

187

187

Pharmacy Times

JULY 26, 2022

A variety of cannabidiol (CBD) products incorrectly listed their CBD and tetrahydrocannabinol content, in addition to making therapeutic and cosmetic claims without FDA approval.

Labelling 123

Labelling FDA 123

Pharmacy Times

MAY 9, 2023

With or without US federal regulation, CBD companies should provide consumers with more transparent information about their products.

123

123

Drug Store News

AUGUST 25, 2023

The powdered drink mixes—available in Lemonade and Berry Medley flavors—are infused with 25 mg of 100% CBD per serving.

98

98

Pharmafile

JANUARY 27, 2023

The FDA is calling on the US Congress to work with them on a new regulatory pathway for cannabidiol (CBD). CBD is the non-psychoactive ingredient from the cannabis plant generally considered to have wellness properties. According to the FDA, there have been some safety concerns around CBD, especially with its long-term use.

FDA 88

FDA Communication 88

STAT

JANUARY 26, 2023

WASHINGTON — The FDA is giving up on trying to figure out a way to regulate CBD on its own. Then-FDA Commissioner Scott Gottlieb stood up a working group in April 2019 aimed at figuring out whether they could stand up a pathway for supplement makers or food companies to sell CBD products legally. Read the rest…

FDA 105

FDA 105

The Checkup by Singlecare

MARCH 23, 2023

An estimated 1 in 3 Americans have tried CBD at least once. As the most accessible healthcare professionals , pharmacists can play a crucial role in helping patients determine if a CBD or marijuana product may be safe for them. Cannabidiol (CBD) is also a cannabinoid, but its consumption does not cause a “high.”

Controlled Substances 52

Controlled Substances Medical Records Chemotherapy Compounding 52

The Checkup by Singlecare

APRIL 27, 2023

The use of cannabidiol (CBD), whether in oils, gummies, or creams, is rapidly growing in the United States. In 2022 alone, the consumer market size for CBD reached around $16 billion and is expected to nearly quadruple by 2032. Taking CBD and blood thinners, in particular, could lead to serious drug interactions and adverse effects.

Dosage 52

Dosage Compounding FDA 52

PioneerRx

MARCH 1, 2023

The new star of the game, CBD, has taken off in popularity in recent years. CBD is touted for its… OTC products are a great way to boost revenue in your pharmacy.

52

52

STAT

FEBRUARY 3, 2023

The dietary supplement industry has been begging for federal oversight of products containing cannabidiol (CBD), a non-psychoactive compound found in the cannabis plant that is being incorporated into a bewildering range of oils, tinctures, edibles, and other products. But the FDA turned down industry trade groups , and for good reason.

FDA 92

FDA Compounding 92

PharmExec

MARCH 12, 2024

The trial of a pharmaceutical-grade CBD for social anxiety disorder, which was the first of its kind to be approved by the FDA, is expected to receive top line results next month.

FDA 40

FDA 40

Fierce Pharma

DECEMBER 1, 2022

PureTech readies oral CBD capsule for clinic to challenge Jazz’s Epidiolex. Thu, 12/01/2022 - 11:05.

84

84

Drug Topics

SEPTEMBER 8, 2022

Addressing patient concerns about cannabidiol can be the key to patient satisfaction.

211

211

Pharmaceutical Technology

DECEMBER 22, 2023

Discover the groundbreaking patent granted to Jazz Pharmaceuticals for using CBD in treating treatment-resistant epilepsy. Learn about the specific dosage options and the significant reduction in seizure frequency. A must-read for researchers and medical professionals.

Dosage 40

Dosage 40

Drug Topics

SEPTEMBER 14, 2022

No federal agency has taken charge of regulating cannabidiol products, leaving decisions up to the individual states.

212

212

Drug Topics

SEPTEMBER 7, 2022

Even “THC-free” cannabidiol products may contain trace amounts of THC.

244

244

Drug Topics

MAY 15, 2023

Balanced products showed greater improvements compared to either CBD-dominant or THC-dominant products.

187

187

Drug Topics

SEPTEMBER 7, 2022

Alex Capano, DNP, CRNP, FNP-BC, discusses what cannabidiol can do in women's health from pelvic pain to fertility to cancer.

112

112

Pharmacy Times

SEPTEMBER 25, 2023

An increase in cannabis use has led to growing concerns surrounding interactions between its components, THC and CBD, and prescription medications.

139

139

Drug Store News

APRIL 21, 2023

A wider range of products offers opportunities for retail pharmacies.

91

91

Drug Topics

JANUARY 27, 2023

The agency intends to work with Congress to create a pathway that balances the desire for access with regulatory oversight and risk management.

FDA 98

FDA 98

Drug Topics

DECEMBER 15, 2022

Research examines how cannabidiol impacts plasma endocannabinoid when consumed along with delta-9-tetrahydrocannabinol.

98

98

Hospital Pharmacy Europe

JUNE 14, 2023

Although the plant contains hundreds of compounds, the two most well studied are tetrahydrocannabinol (THC) and cannabidiol (CBD). THC vs CBD With a clear body of evidence implicating the development of adverse CV outcomes among cannabis users, a limitation of the data is that it is derived from self-reported, recreational use.

Compounding 98

Compounding Hospitals 98

Outsourcing Pharma

FEBRUARY 15, 2024

dsm-firmenich, today (February 15) announces its exclusive partnership with Zerion Pharma A/S to unlock a new era in cannabinoid innovation that champions patient-centric formulations.

64

64

Drug Store News

MARCH 1, 2023

The new line includes tincture and soft gel products.

98

98

PharmExec

MARCH 14, 2024

Although research on cannabinoids is now allowed in a growing number of countries, there are still a number of restrictions and corresponding licenses and permits required to work with these chemicals.

52

52

Drug Store News

MARCH 24, 2023

+PlusCBD Daily Balance THC-Free products provide the benefits of CBD without the effects of THC, the company said.

105

105

Outsourcing Pharma

NOVEMBER 2, 2023

The pharmaceutical and nutritional products specialist dsm-firmenich aims to make better formulations of cannabidiol (CBD).

73

73

Drug Store News

OCTOBER 4, 2022

Sleep Soft Gels work to improve sleep and Slim Soft Gels help consumers curb cravings with natural and clinically studied hemp extract, the companies said.

97

97

Pharmacy Times

SEPTEMBER 8, 2022

Patients should discuss efficacy and potential drug interactions with clinicians before use, study authors indicate.

132

132

BuzzRx

SEPTEMBER 30, 2022

Food and Drug Administration approved Epidiolex , the first plant-based CBD (cannabidiol) formulation for the treatment of two rare forms of childhood-onset epilepsy: Lennox-Gastaut syndrome (LGS) and Dravet syndrome. This CBD oral solution can be used in adults and children as young as 1 year old. Does cannabis help seizures?

FDA 64

FDA Compounding Labelling 64

PioneerRx

AUGUST 23, 2022

A simple green leaf can create endless opportunities — and Matthew Frazier made sure he didn’t miss out. From the hills of ancient China to the hustle-and-bustle.

58

58

Outsourcing Pharma

DECEMBER 6, 2022

PureTech plans to take LYT-310 into the clinic, with the expectation that an oral capsule form of delivery could prove more effective than oil-based formulations.

52

52

Outsourcing Pharma

JANUARY 25, 2022

The agency has given the go-ahead on an IND application for a study evaluating Ananda Scientificâs Nantheia ATL5, a candidate for treating opioid use disorder.

FDA 94

FDA 94